Collaboration to leverage VantAI's expertise in generative AI and geometric deep learning to identify molecular glues against targets of interest with an option to...
Bristol Myers Squibb announced the first disclosure of primary analysis results from the high-risk, second-line cohort of TRANSCEND FL, an open-label, global, multicenter, Phase...